Tapewire

Nasdaq · USD

AVTX

Avalo Therapeutics, Inc.

Export transactions ↓
Tapewire entity
4936
SEC CIK
0001534120
Parsed reports
480

Last 12 months

Inside the activity.

0 purchase rows · 43 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202608
May 2026020
Jun 202602
Jul 202601
Aug 202607
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 10, 2016 Filed Apr 1, 2019 17:32 UTC
Hacksell UliDirector
PurchaseCommon Stock 10,000 $1.07 $10,700.00
Disclosure

SEC source: 0001578563-19-000008 · primary_doc.xml · nonDerivative · entry 1

Hacksell Uli · CIK 0001291962 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · shares: These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 15:10 UTC
BLECH ISAACDirector
GrantEmployee Stock Option (Right to Buy) · Derivative 3,723 $0.00 Strike: $4.23 $0.00
Disclosure

SEC source: 0001179110-16-030160 · edgar.xml · derivative · entry 1

BLECH ISAAC · CIK 0000905536 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,723

Underlying: Common Stock · 3,723 shares

Expires 2026-09-29

F1 · derivative.exercise_date: The stock options immediately vested and became exercisable in full upon grant on September 30, 2016.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 19:12 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 2,105 $0.00 Strike: $4.23 $0.00
Disclosure

SEC source: 0001179110-16-030162 · edgar.xml · derivative · entry 1

Persson Magnus · CIK 0001653222 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,105

Underlying: Common Stock · 2,105 shares

Expires 2026-09-29

F1 · derivative.exercise_date: The stock options immediately vested and became exercisable in full upon grant on September 30, 2016.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 19:11 UTC
Gutry PhilDirector
GrantEmployee Stock Option (Right to Buy) · Derivative 886 $0.00 Strike: $4.23 $0.00
Disclosure

SEC source: 0001179110-16-030161 · edgar.xml · derivative · entry 1

Gutry Phil · CIK 0001653224 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 886

Underlying: Common Stock · 886 shares

Expires 2026-09-29

F1 · derivative.exercise_date: The stock options immediately vested and became exercisable in full upon grant on September 30, 2016.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 19:10 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 1,706 $0.00 Strike: $4.23 $0.00
Disclosure

SEC source: 0001179110-16-030159 · edgar.xml · derivative · entry 1

BAUER EUGENE A · CIK 0001210524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,706

Underlying: Common Stock · 1,706 shares

Expires 2026-09-29

F1 · derivative.exercise_date: The stock options immediately vested and became exercisable in full upon grant on September 30, 2016.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 19:09 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 1,883 $0.00 Strike: $4.23 $0.00
Disclosure

SEC source: 0001179110-16-030157 · edgar.xml · derivative · entry 1

Aasen Thomas H · CIK 0001291969 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,883

Underlying: Common Stock · 1,883 shares

Expires 2026-09-29

F1 · derivative.exercise_date: The stock options immediately vested and became exercisable in full upon grant on September 30, 2016.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.